Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models

Currently, the International Prognostic Index (IPI) is the most used and reported model for prognostication in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL). IPI-like variations have been proposed, but only a few have been validated in different populations (e.g., revised IPI (...

Descripción completa

Detalles Bibliográficos
Autores principales: Jelicic, Jelena, Juul-Jensen, Karen, Bukumiric, Zoran, Roost Clausen, Michael, Ludvigsen Al-Mashhadi, Ahmed, Pedersen, Robert Schou, Poulsen, Christian Bjørn, Brown, Peter, El-Galaly, Tarec Christoffer, Stauffer Larsen, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575851/
https://www.ncbi.nlm.nih.gov/pubmed/37833260
http://dx.doi.org/10.1038/s41408-023-00930-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575851/
https://www.ncbi.nlm.nih.gov/pubmed/37833260
http://dx.doi.org/10.1038/s41408-023-00930-7

Ejemplares similares